Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01089504 · ClinicalTrials.gov registry record · Phase 4
Prophylactic Phenobarbital After Neonatal Seizures
A Phase 4 study, sponsored by University of Rochester.
- Terminated
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT01089504 is a Phase 4 study that was terminated before completion, run by University of Rochester. The registered enrollment target is 13 participants.
The verdict
NCT01089504, a Phase 4 study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
The treatment of infants with medications after their seizures have stopped is very variable. No one knows if continuing treatment with phenobarbital for up to several months is helpful or harmful. This clinical trial is designed to help answer that question and provide data that will help determine standard of care for these children.
Interventions
- DRUG placebo
- DRUG phenobarbital
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2010-09 |
| Est. Completion | 2014-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01089504
The ClinicalTrials.gov registry entry for NCT01089504 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01089504 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01089504 about?
NCT01089504 is a clinical study titled "Prophylactic Phenobarbital After Neonatal Seizures". The treatment of infants with medications after their seizures have stopped is very variable. No one knows if continuing treatment with phenobarbital for up to several months is helpful or harmful. This clinical trial is designed to help answer that question and provide data that will help determine...
What is the current status of trial NCT01089504?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2010-09. Estimated completion is 2014-11.
What interventions are being tested in trial NCT01089504?
The interventions under investigation include: placebo (DRUG), phenobarbital (DRUG).
Who is sponsoring clinical trial NCT01089504?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.